Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes
Edwards Pradenas, Benjamin Trinité, Víctor Urrea, Sílvia Marfil, Carlos Ávila‐Nieto, Maria Luisa Rodrı́guez de la Concepción, Ferran Tarrés-Freixas, Silvia Pérez-Yanes, Carla Rovirosa, Erola Ainsua‐Enrich, Jordi Rodon, Júlia Vergara‐Alert, Joaquím Segalés, Vı́ctor Guallar, Alfonso Valencia, Nuria Izquierdo‐Useros, Roger Paredes, Lourdes Mateu, Anna Chamorro, Marta Massanella, Jorge Carrillo, Bonaventura Clotet, Julià Blanco
Topics & Concepts
Coronavirus disease 2019 (COVID-19)PandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakCornerstoneMedicineImmunityAntibodyVirologyNeutralizing antibodyImmunologyImmune systemInternal medicineOutbreakGeographyDiseaseInfectious disease (medical specialty)ArchaeologySARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19COVID-19 Clinical Research Studies